BCNU

DRUG18 trials

Sponsors

H. Lee Moffitt Cancer Center and Research Institute, University of Arkansas, Lymphoma Study Association, European Mantle Cell Lymphoma Network, Stanford University

Conditions

Acute GVHDAdenocarcinoma of the BreastBRCA1 MutationBRCA2 MutationBreast Cancer MetastaticBreast Cancer Stage IVCentral Nervous System LymphomaDiffuse Large B-Cell Lymphoma

Phase 1

Post-transplant Autologous Cytokine-induced Killer (CIK) Cells for Treatment of High Risk Hematologic Malignancies

CompletedNCT00477035

Sally AraiLeukemia, Multiple Myeloma

Start: 2006-05-31End: 2011-03-31Updated: 2017-01-11

Y Zevalin and BEAM in Autologous Stem Cell Transplantation (ASCT) for Lymphoma

CompletedNCT01538472

M.D. Anderson Cancer CenterLymphoma

Start: 2003-09-30End: 2011-11-30Updated: 2014-09-11

SHARON: A Clinical Trial for Metastatic Cancer Using Chemotherapy and Patients' Own Stem Cells

RecruitingNCT04150042

General Oncology, Inc.Adenocarcinoma of the Breast, BRCA1 Mutation, BRCA2 Mutation +17

Start: 2021-01-13End: 2028-12-01Target: 24Updated: 2026-01-29

Tebentafusp-tebn With LDT in Metastatic UM

RecruitingNCT06626516

Thomas Jefferson UniversityMetastatic Uveal Melanoma

Start: 2025-10-15End: 2032-08-31Target: 109Updated: 2025-11-28

Phase 2

Peripheral Stem Cell Transplantation in Treating Patients With Non-Hodgkin's Lymphoma or Hodgkin's Disease

CompletedNCT00005613

H. Lee Moffitt Cancer Center and Research InstituteLymphoma

Start: 1996-03-31End: 2010-06-30Updated: 2013-06-04

Sirolimus & Mycophenolate Mofetil as GVHD Prophylaxis in Myeloablative, Matched Related Donor HCT

CompletedNCT00350181

Stanford UniversityAcute GVHD, Hematologic Diseases, Leukemia +1

Start: 2006-08-31End: 2010-04-30Updated: 2021-09-23

Autologous Followed by Non-myeloablative Allogeneic Transplantation for Non-Hodgkin's Lymphoma

TerminatedNCT00481832

Stanford UniversityLymphoma, Non-Hodgkin

Start: 2007-01-31End: 2017-03-30Updated: 2018-02-14

Autologous and Allogenic Transplantation With Campath-1H for T-Cell Lymphoma

TerminatedNCT00505921

M.D. Anderson Cancer CenterLymphoma

Start: 2003-03-31End: 2009-11-30Updated: 2011-11-16

Natural Killer (NK) Cell Adback After Allogeneic Stem Cell Transplant With Campath-IH Plus Chemorx for Patients With Lymphoid Malignancies

CompletedNCT00536978

M.D. Anderson Cancer CenterLeukemia, Lymphoma

Start: 2007-09-30End: 2010-11-30Updated: 2020-09-24

Trial for Patients With Newly Diagnosed Primary Central Nervous System (CNS) Lymphoma

CompletedNCT01011920

International Extranodal Lymphoma Study Group (IELSG)Central Nervous System Lymphoma

Start: 2009-11-01End: 2024-12-19Updated: 2026-03-19

Autologous Transplant in HIV Patients (BMT CTN 0803)

CompletedNCT01141712

Medical College of WisconsinHIV, Lymphoma

Start: 2010-04-30End: 2016-06-30Updated: 2023-01-04

Auto Stem Cell Transplant for Lymphoma Patients

RecruitingNCT03125642

Masonic Cancer Center, University of MinnesotaHodgkin Lymphoma, Non-Hodgkin Lymphoma

Start: 2017-04-20End: 2027-04-30Target: 150Updated: 2025-11-04

Phase 3

UARK 98-026 TT II: Multiple Myeloma Evaluating Anti-Angiogenesis With Thalidomide and Post-Transplant Consolidation Chemotherapy

CompletedNCT00083551

University of ArkansasMultiple Myeloma

Start: 1998-08-31End: 2014-08-31Updated: 2015-11-23

R-ICE Versus R-DHAP in Patients Aged 18-65 With Relapse Diffuse Large B-cell Lymphoma

CompletedNCT00137995

Lymphoma Study AssociationLymphoma, Large-Cell, Diffuse

Start: 2003-06-30End: 2008-10-31Updated: 2019-08-28

Efficacy of R-CHOP vs R-CHOP/R-DHAP in Untreated MCL

European Mantle Cell Lymphoma NetworkLymphoma, Mantle-Cell

Start: 2004-07-31End: 2014-12-31Target: 360Updated: 2012-09-10

Dose Dense Chemotherapy + Rituximab +/-Intensified High Dose Chemoimmunotherapy With Support of Peripheral Autologous Stem Cell in Diffuse Large B-Cell Lymphoma

Fondazione Italiana Linfomi - ETSDiffuse Large B-Cell Lymphoma, IPI≥2

Start: 2006-01-31End: 2013-09-30Target: 399Updated: 2011-02-15

Unknown Phase

Rituxan + BEAM and Auto Stem Cell Transplant for High Risk Lymphoma or Hodgkin's Disease

CompletedNCT01702961

Baylor College of MedicineHodgkin's Disease, Lymphoma

Start: 2002-06-30End: 2017-01-31Updated: 2018-12-19

Therapeutic Targeting of Sex Differences in Pediatric Brain Tumor Glycolysis

TerminatedNCT03591861

Washington University School of MedicinePediatric Brain Tumor

Start: 2019-05-01End: 2022-11-01Updated: 2022-12-12

Related Papers

Altered mesenchymal and endothelial subsets in interstitial bone marrow and focal lesions in myeloma patients and SCID-hu mice.

2025-06-12

Long-Term Follow-Up of Patients With Multiple Myeloma Treated on Earlier Total Therapy Protocols

JAMA Oncology2025-06-051 citations

Aberrant Cytoplasmic Expression of p16 Is a New Strong Prognostic Marker in Young MCL Patients Treated By Frontline Cytarabine-Based Immunochemotherapy, a Study from the Lysa Group, Nordic Lymphoma Group and the European MCL Network

Blood2024-11-05

<i>Intensified Immunochemotherapy with Autologous Stem Cell Transplantation for Mantle Cell Lymphoma - Could It Still be Considered the Standard of Care?</i>

Blood2024-11-05

Validation of POD24 As a Robust Early Clinical End Point of Poor Survival in Mantle Cell Lymphoma from 1280 Patients on Clinical Trials

Blood2023-11-029 citations

Curability of multiple myeloma (MM) based on relative survival rate (RSR) in patients (pts) treated on earlier total therapy (TT) protocols.

Journal of Clinical Oncology2023-06-011 citations

P+R‐ICE: PEMBROLIZUMAB IN COMBINATION WITH R‐ICE CHEMOTHERAPY IN RELAPSED/REFRACTORY DIFFUSE LARGE B‐CELL LYMPHOMA ‐ ONGOING TRIAL

Hematological Oncology2023-06-01

The SHARON trial: A study of melphalan, BCNU, hydroxocobalamin, ascorbic acid, and autologous stem cell rescue for metastatic pancreatic cancer with an inherited BRCA mutation.

Journal of Clinical Oncology2023-01-24

Combining Plasma Cell Leukemia-like Status with the Second Revision of the International Staging System Improves Risk Classification

Blood2022-11-151 citations

Indirect comparison of tisagenlecleucel and historical treatments for relapsed/refractory diffuse large B-cell lymphoma

Blood Advances2022-01-1420 citations

A Clinical Prognostic Model Based on Machine Learning from the Fondazione Italiana Linfomi (FIL) MCL0208 Phase III Trial

Cancers2021-12-3113 citations

Prognostic impact of <i>TP53</i> mutation in newly diagnosed diffuse large B‐cell lymphoma patients treated in the FIL‐DLCL04 trial

British Journal of Haematology2021-12-2331 citations

A three-gene signature based on <i>MYC</i>, <i>BCL-2</i> and <i>NFKBIA</i> improves risk stratification in diffuse large B-cell lymphoma

Haematologica2020-08-1311 citations

Whole-brain radiotherapy or autologous stem-cell transplantation as consolidation strategies after high-dose methotrexate-based chemoimmunotherapy in patients with primary CNS lymphoma: results of the second randomisation of the International Extranodal Lymphoma Study Group-32 phase 2 trial.

2017-10-17258 citations

Rituximab-dose-dense chemotherapy with or without high-dose chemotherapy plus autologous stem-cell transplantation in high-risk diffuse large B-cell lymphoma (DLCL04): final results of a multicentre, open-label, randomised, controlled, phase 3 study.

2017-06-2899 citations

Effects on Survival and Neurocognitive Functions of Whole-Brain Radiotherapy (WBRT) and Autologous Stem Cell Transplantation (ASCT) as Consolidation Options after High-Dose Methotrexate-Based Chemoimmunotherapy in Patients with Newly Diagnosed Primary CNS Lymphoma (PCNSL): Results of the Second Randomization of the IELSG32 Trial

Blood2016-12-022 citations

Evaluation of Immune Recovery Following Autologous Hematopoietic Cell Transplantation in HIV-Related Lymphoma: Results of the BMT CTN 0803/AMC 071 Trial

Blood2016-12-02

Erythropoietin (EPO)-receptor signaling induces cell death of primary myeloma cells in vitro.

2016-08-318 citations

Addition of high-dose cytarabine to immunochemotherapy before autologous stem-cell transplantation in patients aged 65 years or younger with mantle cell lymphoma (MCL Younger): a randomised, open-label, phase 3 trial of the European Mantle Cell Lymphoma Network.

2016-06-14280 citations

Autologous hematopoietic cell transplantation for HIV-related lymphoma: results of the BMT CTN 0803/AMC 071 trial

Blood2016-06-1492 citations

6 more papers not shown